T. Rowe Price Investment Management
CLBT icon

T. Rowe Price Investment Management’s Cellebrite CLBT Stock Holding History

T. Rowe Price Investment Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.7M Sell
3,315,392
-5,199,502
-61% -$78.4M 0.03% 369
2025
Q4 		$154M Sell
8,514,894
-1,530,087
-15% -$27.5M 0.1% 193
2025
Q3 		$186M Buy
10,044,981
+3,527,104
+54% +$55.4M 0.11% 186
2025
Q2 		$104M Buy
6,517,877
+3,381,546
+108% +$60.3M 0.07% 271
2025
Q1 		$60.9M Buy
+3,136,331
New +$66M 0.04% 362

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

T. Rowe Price Investment Management's CLBT Position: Q1 2026 in Review

T. Rowe Price Investment Management reduced its Cellebrite (CLBT) stake by 61% in Q1 2026, selling an estimated $78.4M and leaving 3,315,392 shares worth $45.7M. The position accounts for 0.03% of the portfolio, ranked #369.

T. Rowe Price Investment Management first reported a position in CLBT in Q1 2025 and has held it in 5 quarters since. The position peaked at $186M in Q3 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • T. Rowe Price Investment Management held 3,315,392 shares of Cellebrite worth $45.7M as of Q1 2026.
  • T. Rowe Price Investment Management sold 5,199,502 Cellebrite shares in Q1 2026, an estimated $78.4M.
  • Cellebrite made up 0.03% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #369 holding.
  • T. Rowe Price Investment Management first reported a position in Cellebrite in Q1 2025 and has held it in 5 quarters since.
  • T. Rowe Price Investment Management's Cellebrite position peaked at $186M in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.